Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fluocinolone is a synthetic corticosteroid used primarily as a topical medication to treat various inflammatory and pruritic (itchy) skin conditions, including eczema, psoriasis, and atopic dermatitis. It works by activating the glucocorticoid receptor in cells, which leads to the induction of proteins that inhibit phospholipase A2. This action reduces the release of arachidonic acid and subsequently decreases the synthesis of pro-inflammatory mediators such as prostaglandins and leukotrienes. The result is reduced swelling, redness, itching, and discomfort in affected areas. Fluocinolone is available in several formulations including cream, ointment, solution, oil, shampoo for scalp use, and sometimes as an ear drop or ophthalmic implant for other indications[1][3][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluocinolone.